1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6637B6B11A6D0D32D65257C7F0067BB58
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/637B6B11A6D0D32D65257C7F0067BB58!OpenDocument
18
19OpenDocument
2044.210.149.205
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services Market Access Payer Market Research

Report Summary: Increasing Market Access through Innovative Payer Market Research: Assessing New Tools & Technologies to Gain Insight into Payer Decision Making

ID: PSM-304A


Features:

Best Practices


Pages/Slides: 12


Published: Pre-2019


Delivery Format: , PDF


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • VIEW TOC AND LIST OF EXHIBITS

For a complimentary report summary, click
"Download FREE Excerpt".

The health care marketplace is rapidly and sometimes chaotically evolving. The overall influence of payers is rising and the types of payers influencing health care access is diversifying. Any company hoping to compete and win in this “brave new world” must understand the “payer ecosystem” and learn to navigate through it.

Best Practices, LLC conducted this research to probe how health care companies structure internal research groups conducting payer research, and it assesses what market research approaches are most effective and innovative for understanding diverse payer needs, preferences and decision-making. This study also examines what research techniques work best during all product lifecycle stages to ensure access for therapies through national, regional and government payers and through Accountable Care Organizations and Integrated Health Delivery Networks.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Insurance; Manufacturing; Consumer Products; Biopharmaceutical; Chemical; Market Research; Education; Consulting; Communications


Companies Profiled:
Abbott; Hobart Innovations; Abbott Diabetes Care; Abbott Nutrition; Astellas; AstraZeneca; AstraZeneca Neuroscience; Amgen; Baxter International; CDMI; Boehringer Ingelheim; Biogen Idec; Bayer; Biomet; Baxter BioScience; Drager; GE Healthcare; Gilead Sciences; Genentech; EMD Serono; GlaxoSmithKline ; GSW; Galderma; Ipsen; Joerns Healthcare; Endo Pharmaceuticals; Indi; Novo Nordisk; Mako Surgical Corp.; Medtronic CRDM; Kadmon Pharmaceuticals; Xcenda; Medtronic Neuromodulation; Phillips; NPS; Masimo; Walgreens; Health Interactions


Table of Contents

Research Overview
  • Universe of Learning
  • Key Findings & Insights for Managing the Payer Ecosystem
  • Mapping the Rapidly Evolving Payer Ecosystem
  • Effective Tools & Technologies to Understand Payer Decision-making
  • Key Trends in Managed Markets Contracting Research
  • Key Trends in Payer Formulary & Tracking Research
  • Understanding What Drives National & Regional Payer Decision-making
  • Understanding What Drives Government Payer Decision-making
  • ACOs & IDNs Are Rising in Importance
  • Cross-Functional Collaboration & Communication Are Critical
  • Optimizing Payer Research Structures, Roles & Resources
  • Preparing to Compete in an Outcomes-oriented World
  • Appendix